Supplementary Table S4 from Tumor and Immune Dynamics Following Sequential CDK4/6 and PD-1 Inhibition: Results from a Phase 2 Study in Dedifferentiated Liposarcoma

2026 Open access

Read full text
Authors: Evan Rosenbaum P. E, Rodrigo Gularte‐Mérida, Evan Seffar, Jasme Lee, Mathew Adamow, Martina Bradić, Mark Andrew Dickson, Viswatej Avutu, Lauren Baker Banks, Jason Earl Chan, Ping Chi, Mrinal M. Gounder
+18 more Ciara Marie Kelly, Mary Louise Keohan, Robert G. Maki, Sujana Movva, Damon R. Reed, Rhoena Desir, Matthew D. Biniakewitz, Joseph Patrick Erinjeri, Robert A. Lefkowitz, Phillip Wong, Cristina R. Antonescu, Li‐Xuan Qin, Katherine S. Panageas, Ronglai Shen, Samuel Singer, Andrew Koff, William D. Tap, Sandra P. D’Angelo
DOI: 10.1158/2767-9764.31429921
Cited by: 0

Abstract

Supplementary Table S4. Intra-cluster differential pathway analysis between pre- and post-retifanlimab biopsies

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Sarcoma Diagnosis and Treatment Lymphoma Diagnosis and Treatment

Publication details

Publication date
27 February 2026
Language
EN